Roots Analysis has announced theaddition of “Human Microbiome Market, 2019-2030”report to its list of offerings
The report features an in-depthanalysis, highlighting the diverse capabilities of stakeholders engaged in thisdomain. In addition to other elements, the study includes:
§ Adetailed assessment of thecurrent market landscape of microbiome therapeutics, providing information ondrug / therapy developer(s).
§ Elaborate profiles of keyplayers (established after 2005) that are engaged in the development ofmicrobiome therapeutics.
§ A detailed review of the currentmarket landscape of microbiome diagnostic tests, brief profiles of populardiagnostic developers and indicative list of screening and profiling test kits.
§ A detailed assessment of thecurrent market landscape of FMT therapies, a geographical clinical trialanalysis and information on various stool banks.
§ A detailed business portfolioanalysis based on an attractiveness and competitiveness (AC) framework.
§ An analysis of the variedmicrobiome-focused initiatives of big pharma players.
§ An analysis of the start-ups /small-sized players engaged in the development of microbiome therapeutics anddiagnostics.
§ An assessment of the mostcommonly targeted therapeutic indications and details of microbiome-based drugs.
§ An analysis of the investmentsmade at various stages of development in start-ups / small-sized companies.
§ An indicative list of contractmanufacturers, in-house manufacturers and CROs that currently claim to have thenecessary capabilities.
§ An assessment of the emergingrole of big data highlighting efforts focused on the development andimplementation of various algorithms / tools to analyze data generated from inthe microbiome research.
§ An informative case study on thevarious other applications of microbiome products, such as agriculture, animalhealth, plant health, food products
§ A detailed market forecast, featuring analysis of thecurrent and projected future opportunity across key market segments (listedbelow)
segments:
§ Typeof Therapy (Tx)
§ PrescriptionDrug
§ Prebiotics
§ Probiotics
§ Typeof Molecule (Tx)
§ SmallMolecules
§ Biologics
§ TargetIndication (Tx+Dx)
§ AcneVulgaris
§ AtopicDermatitis
§ Clostridiumdifficile Infection
§ ColorectalCancer
§ Crohn’sDisease
§ Diabetes
§ IrritableBowel Syndrome
§ LactoseIntolerance
§ LungCancer
§ Nonalcoholicsteatohepatitis (NASH)
§ Obesity
§ Ulcerativecolitis
§ TherapeuticArea (Tx+Dx)
§ AutoimmuneDisorders
§ DentalDisorders
§ Digestiveand Gastrointestinal Disorders
§ DermatologicalDisorders
§ InfectiousDisease
§ MetabolicDisorders
§ Oncology
§ Others
§ KeyGeographical Regions (Tx+Dx)
§ NorthAmerica
§ Europe
§ Asia-Pacificand Rest of the World
Keycompanies covered in the report
§ 4D Pharma
§ ArmataPharmaceuticals
§ Evelo Biosciences
§ Rebiotix (Acquired byFerring Pharmaceuticals)
§ Seres Therapeutics
§ Vedanta Biosciences
Formore information please click on the following link:
https://www.rootsanalysis.com/reports/view_document/human-microbiome-market/281.html oremail sales@rootsanalysis.com
Other Recent Offerings:
1. Antibody Drug Conjugates Market (5th Edition), 2019-2030
2. Gene Therapy Market (3rd Edition), 2019 - 2030
3. Global T-Cell (CAR-T, TCR, and TIL) Therapy Market (4th Edition), 2019 – 2030
4. Synthetic Lethality-based Drugs and Targets Market, 2019-2030
About Roots Analysis
Roots Analysis is one of the fastest growing marketresearch companies, sharing fresh and independent perspectives in thebio-pharmaceutical industry. The in-depth research, analysis and insights aredriven by an experienced leadership team which has gained many years ofsignificant experience in this sector. If you’d like help with your growingbusiness needs, get in touch at info@rootsanalysis.com
Contact Information
Roots Analysis Private Limited
Gaurav Chaudhary
+1 (415) 800 3415
gaurav.chaudhary@rootsanalysis.com
